glp-1 and type 2 diabetes Understanding in Clinical Focus on GLP-1 Agonists
Description
In the LEAD series of studies, clinical data demonstrated that treatment with liraglutide for 26 weeks can reduce SBP [4]
12, Oct
Diabetes Care 36, 25432550
That is not what these four weeks are for
author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law
